These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21477135)

  • 1. Prolonged lymphopenia in a patient with lymphoma and severe Pandemic influenza A H1N1 2009 virus infection.
    Ñamendys-Silva SA; Pérez-Jiménez C; Cornejo-Juárez P; Vilar-Compte D; Volkow P
    Influenza Other Respir Viruses; 2011 May; 5(3):167-9. PubMed ID: 21477135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
    Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
    N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
    Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
    Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent oseltamivir-resistant pandemic influenza A/H1N1 infection in an adult with cystic fibrosis.
    Flight WG; Bright-Thomas R; Mutton K; Webb K; Jones A
    BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
    J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
    J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case.
    Speers DJ; Williams SH; Pinder M; Moody HR; Hurt AC; Smith DW
    Med J Aust; 2010 Feb; 192(3):166-8. PubMed ID: 20121687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(32):893-6. PubMed ID: 19696719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahost emergent dynamics of oseltamivir-resistant virus of pandemic influenza A (H1N1) 2009 in a fatally immunocompromised patient.
    Hamada N; Imamura Y; Hara K; Kashiwagi T; Imamura Y; Nakazono Y; Chijiwa K; Watanabe H
    J Infect Chemother; 2012 Dec; 18(6):865-71. PubMed ID: 22661221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir.
    Nguyen HT; Fry AM; Loveless PA; Klimov AI; Gubareva LV
    Clin Infect Dis; 2010 Oct; 51(8):983-4. PubMed ID: 20858074
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
    Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
    Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia.
    Salata C; Sgarabotto D; Del Vecchio C; Solimbergo E; Marini G; Nicolè S; Franchin E; Parolin C; Calistri A; Palù G
    J Infect Chemother; 2019 Jul; 25(7):543-546. PubMed ID: 31014561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.
    van der Vries E; Jonges M; Herfst S; Maaskant J; Van der Linden A; Guldemeester J; Aron GI; Bestebroer TM; Koopmans M; Meijer A; Fouchier RA; Osterhaus AD; Boucher CA; Schutten M
    J Clin Virol; 2010 Jan; 47(1):34-7. PubMed ID: 19857993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.
    Higuera Iglesias AL; Kudo K; Manabe T; Corcho Berdugo AE; Corrales Baeza A; Alfaro Ramos L; Guevara Gutiérrez R; Manjarrez Zavala ME; Takasaki J; Izumi S; Bautista E; Perez Padilla JR
    PLoS One; 2011; 6(7):e21838. PubMed ID: 21760915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients.
    Renaud C; Boudreault AA; Kuypers J; Lofy KH; Corey L; Boeckh MJ; Englund JA
    Emerg Infect Dis; 2011 Apr; 17(4):653-60; quiz 765. PubMed ID: 21470455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy.
    Charlier C; Enouf V; Lanternier F; Grandadam M; Amazzough K; Blanche S; Lecuit M; Lortholary O; van der Werf S
    Clin Microbiol Infect; 2009 Dec; 15(12):1189-91. PubMed ID: 19681951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.